Austria, Concep J.
HRN: 26-16-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/04/2024
11/10/2024
IV
600 Mg
Q8
INFECTED WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes